I Allen
Family Medicine · Silver Spring, MDNPI 1043742117
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 145 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 16.3% — the pattern of someone who eats at a lot of different presentations.
Across 145 payments — averaging $23.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$563
- AbbVie$497
- Lilly USA, LLC$402
- Amgen$311
- Pfizer$301
- Bayer$251
- plus $1K from 20 others
What the payments were for
- Food & beverage$3,446100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $563 |
| AbbVie | 16 | $497 |
| Lilly USA, LLC | 18 | $402 |
| Amgen | 12 | $311 |
| Pfizer | 14 | $301 |
| Bayer | 7 | $251 |
| AstraZeneca | 13 | $245 |
| Boehringer Ingelheim | 10 | $189 |
| Esperion Therapeutics, Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 4 | $71 |
| Seqirus USA Inc | 4 | $71 |
| Phathom Pharmaceuticals, Inc. | 3 | $56 |
| Exact Sciences | 3 | $50 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Dexcom, Inc. | 1 | $33 |
| Phadia US Inc. | 2 | $33 |
| GSK | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $26 |
| Corcept Therapeutics | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Johnson & Johnson | 1 | $18 |
| Merck | 1 | $16 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,446 in reported general payments places this provider in the 85th percentile of 1,193 family medicine providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rosuvastatin Calcium | 16 | $438 |
| Losartan Potassium | 15 | $279 |
| Atorvastatin Calcium | 15 | $151 |
| Levothyroxine Sodium | 22 | $132 |
| Amlodipine Besylate | 17 | $103 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Silver Spring
- Cynthia KleppingerSilver Spring$51K
- Jean WelshSilver Spring$24K
- Adolph JohnsonSilver Spring$11K
- Mark MajorSilver Spring$10K
- Karen DonaldsonBaltimore$899K
- Louis JacquesBaltimore$522K
- Michael ObiefuneBaltimore$291K
- Thomas LawrenceBerlin$254K
- Casey ScottCambridge$88K
- Daljeet SalujaBaltimore$63K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.